Galliker Stephens S

Avg. Two Year Performance

17% Avg. Purchase Return
8% Compound
68% Avg. Sale Return
30% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(11%)(14%)(9%)35%17%
Purchase Success Rate0 of 10 of 10 of 11 of 11 of 1
Average Sale Return95%97%97%99%68%
Sale Success Rate2 of 22 of 22 of 22 of 22 of 2

Dyax Corp.

Drugs » Biotechnology

EVP and CFO:

Holdings: 63.14K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Kindred Biosciences, Inc.

Drugs » Biotechnology

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Osteotech Inc.

Health Services » Medical Instruments & Supplies

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Galena Biopharma, Inc.

Drugs » Biotechnology

Director:

Holdings: 36.04K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--